Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs
Juan M. Pericàs(Hospital Clínic de Barcelona), José M. Miró(Universitat Autònoma de Barcelona), Zeina A. Kanafani(American University of Beirut Medical Center), Nuria Fernández‐Hidalgo, Cristiane da Cruz Lamas(Instituto Nacional de Cardiologia), Emanuele Durante‐Mangoni(University of Campania "Luigi Vanvitelli"), Tomáš Freiberger(Masaryk University), Vivian H. Chu(Duke Medical Center), Eugene Athan(Barwon Health), Marta Hernández‐Meneses(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Jaume Llopis(Universitat de Barcelona), Pierre Tattevin(Inserm), Margaret M. Hannan(Mater Misericordiae Hospital), Francisco Nacinovich(Instituto Cardiovascular de Buenos Aires), David Murdoch(The University of Queensland), Jacob Strahilevitz(Hebrew University of Jerusalem)
Cited by 74
Related Papers
Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century
|Archives of Internal Medicine|2009|2.3k
2023 ESC Guidelines for the management of endocarditis
|European Heart Journal|2023|1.6k
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
|Nature Medicine|2005|1k
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
|Clinical Microbiology Reviews|2009|930